Showing results (281-290 of 778) with videos related to

Sort By:
Pageof 78
Biometrics|April 29, 2016
Mixture of time-dependent growth models with an application to blue swimmer crab length-frequency dataLuke R Lloyd-Jones, Hien D Nguyen, Geoffrey J McLachlan, et al.
Arthritis Care & Research|December 23, 2021
Health Literacy and Appropriateness of Self-Care and Pain Management in Osteoarthritis: An Understanding of the Patient's PerspectiveDavid J Hunter, Andrew J McLachlan, Peter R Carroll, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|March 5, 2021
Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospitalArwa Abu Sardaneh, Jonathan Penm, Matthew Oliver, et al.
Bioinformatics (Oxford, England)|May 6, 2006
A mixture model with random-effects components for clustering correlated gene-expression profilesS K Ng, G J McLachlan, K Wang, et al.
Drugs & Aging|August 19, 2009
Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysisPrasad S Nishtala, Sarah N Hilmer, Andrew J McLachlan, et al.
The Journal of Rheumatology|February 3, 2011
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with goutSophie L Stocker, Garry G Graham, Andrew J McLachlan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 24, 2004
Strong intramolecular secondary si.N bonds in trifluorosilylhydrazinesKrunoslav Vojinović, Lorna J McLachlan, Sarah L Hinchley, et al.
British Journal of Clinical Pharmacology|June 1, 1994
Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarinE Chan, A J McLachlan, M Pegg, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2011
An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugsViet Hong Phan, Cindy Tan, Anneliese Rittau, et al.
Pageof 78